Results
1 -
6 of
6Fretz Heinz, Valdenaire Anja, Pothier Julien, Hilpert Kurt, Gnerre Carmela, Peter Oliver, Leroy Xavier, Riederer Markus A..
Identification of 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic Acid (Setipiprant/ACT-129968), a Potent, Selective, and Orally Bioavailable Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2) Antagonist, Journal of Medicinal Chemistry, 2013 Pharmacokinetic interactions between simvastatin and setipiprant, a CRTH2 antagonist, European Journal of Clinical Pharmacology Disposition and Metabolism of Setipiprant, a Selective Oral CRTH2 Antagonist, in Humans, Drugs in R&D Pharmacokinetic/Pharmacodynamic Modelling of Receptor Internalization with CRTH2 Antagonists to Optimize Dose Selection, Clinical Pharmacokinetics Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives, Drugs Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies, Allergy, Asthma & Clinical Immunology